ArticleInternational journal of molecular sciences2026
Analysis of Clinical Impact of CD33 rs12459419 Single-Nucleotide Polymorphism in AML Treated with Intensive Chemotherapy Without Gemtuzumab Ozogamicin.
Sophie Helfenstein et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.